<<

Kx Advisors Strengthens Leadership With Two Additions WASHINGTON DC (March 26, 2020) – Kx Advisors announces Evelyn Tee and Brett Larson have joined the firm. Evelyn Tee joins Kx Advisors as a Vice President in Washington, DC. Evelyn’s background in developing growth strategies for global biopharmaceutical clients is directly applicable in her new role at Kx Advisors. “Evelyn has proven expertise in a range of therapeutic areas, with a strong history of anticipating the needs of her clients” said Dan O’Neill, Senior Vice President. “We know Evelyn will not only cultivate new ideas to serve our clients in the years to come, but also further Kx Advisors' culture by mentoring future leaders.” Prior to Kx Advisors, Evelyn was a management consultant with the Boston Consulting Group and the Life Advisory Practice of EY. Evelyn earned an MBA in Operations and Marketing from the Wharton School at the University of and is a Joseph Wharton Fellow. She also earned a BA in Mathematical Methods in Social Sciences (MMSS), Economics, and International Studies from Northwestern University. Brett Larson joins Kx Advisors as a Principal. He works with our pharma, biotech, and investor clients with a focus on development, due diligence, forecasting, and corporate strategy. “We are fortunate to have someone of Brett’s caliber join us,” said Bob Serrano, Senior Vice President. “Brett’s extensive track record of identifying organic growth and M&A opportunities for leading biopharma clients makes him a strong addition to our firm.” Prior to Kx Advisors, Brett worked at SVB Leerink providing investment banking research coverage for emerging biotech . Brett holds an Executive MBA from Quantic School of Business & and a BA in from Amherst College. About Kx Advisors For more than 30 years, Kx Advisors (operating as Kaiser Associates’ Healthcare Practice) has provided strategy consulting services to help healthcare executives achieve critical business growth goals. With a highly collaborative approach they have developed pragmatic solutions for leading pharmaceutical, biotechnology, medical device, health IT, and digital health clients, with data-driven insights to give those clients the tools to compete and win across the healthcare industry. For more information, or to request an interview, please contact [email protected]

Washington DC Hong Kong